Home › Funds › Avoro Capital Advisors LLC › TSHA

Avoro Capital Advisors LLC position in TSHA

TAYSHA GENE THERAPIES INC · Health Care

Avoro Capital Advisors LLC reported holding 23,888,888 shares of TSHA (TAYSHA GENE THERAPIES INC) in its Q3 2026 13F filing — a position valued at US$116.3M, representing 1.20% of its reported portfolio and ranking #16 among its reported holdings. Avoro Capital Advisors LLC has disclosed TSHA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)23.89M sh
Reported value held$116.34M
Portfolio Weight1.20%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Avoro Capital Advisors LLC's TSHA position evolved

Avoro Capital Advisors LLC first disclosed a stake in TSHA in Q3 2023 at 3,925,000 shares (US$12.4M). The position peaked in Q2 2026 at 23,888,888 shares, worth US$162.7M. Across 13 filings, Avoro Capital Advisors LLC increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 23,888,888 shares valued at US$116.3M. Notable position changes include a 328% increase in Q1 2024 (shares fell 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.92M $12.40M New
Q4 2023 4.36M $7.71M Add
Q1 2024 18.65M $53.53M Add
Q2 2024 18.65M $41.78M Hold
Q3 2024 18.65M $37.49M Hold
Q4 2024 20.00M $34.60M Add
Q1 2025 20.00M $27.80M Hold
Q2 2025 21.70M $50.13M Add
Q3 2025 21.70M $70.96M Hold
Q4 2025 21.70M $119.35M Hold
Q1 2026 21.70M $97.00M Hold
Q2 2026 23.89M $162.68M Add
Q3 2026 23.89M $116.34M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TSHA and 13F data

TSHA (TAYSHA GENE THERAPIES INC) is a Health Care company. 47 other funds we track also report a position in TSHA — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$160.4M), Vestal Point Capital, LP (US$132.2M), RTW INVESTMENTS, LP (US$66.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TSHA

All TSHA fund holders →

FAQ

How long has Avoro Capital Advisors LLC held TSHA?

Avoro Capital Advisors LLC has disclosed TSHA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Avoro Capital Advisors LLC's current position in TSHA?

As of Q3 2026, Avoro Capital Advisors LLC holds 23.89M shares of TSHA (TAYSHA GENE THERAPIES INC), valued at $116.34M, representing 1.20% of its reported portfolio and ranking #16.

Has Avoro Capital Advisors LLC been buying or selling TSHA?

In the latest 13F filing (Q3 2026), Avoro Capital Advisors LLC held unchanged its position in TSHA. The position peaked in Q2 2026 at 23.89M shares.

Which other funds hold TSHA?

Other major institutional holders of TSHA include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, RTW INVESTMENTS, LP, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.